Canada Markets closed

22nd Century Group, Inc. (XXII)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.4200-0.1500 (-5.84%)
At close: 04:00PM EDT
2.4500 +0.03 (+1.24%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close2.5700
Open2.6550
Bid2.3800 x 2900
Ask2.4600 x 36900
Day's Range2.2100 - 2.6900
52 Week Range1.4200 - 4.9800
Volume7,264,041
Avg. Volume1,878,403
Market Cap393.85M
Beta (5Y Monthly)2.01
PE Ratio (TTM)N/A
EPS (TTM)-0.1670
Earnings DateMar 09, 2022 - Mar 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.50
  • GlobeNewswire

    22nd Century Group (Nasdaq: XXII) Supports Federal Proposal to Require Less Nicotine in All U.S. Cigarettes

    FDA’s Proposed Rule Draws on Research That Supports Reduced Nicotine Content Cigarettes Are Less Addictive22nd Century Group’s FDA MRTP Authorized 95% Reduced Nicotine Cigarette Products Is Already Available to Meet Proposed Policy to Reduce Nicotine in All CigarettesVLN® Pilot Sales Across Circle K Stores in the Chicago Area Showing Strong Interest from Adult Smokers BUFFALO, N.Y., June 22, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology co

  • GlobeNewswire

    22nd Century Group (Nasdaq: XXII) Appoints R. Hugh Kinsman as CFO

    CFO of GVB Biopharma to Expand Role, Become CFO of 22nd Century GroupIntegration of GVB Biopharma Proceeding at a Rapid Pace BUFFALO, N.Y., June 16, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company), dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology, today announced the appointment of R. Hugh Kinsman as Chief Financial Officer. Kinsman is currently CFO of GVB Biopharma

  • GlobeNewswire

    22nd Century Group (Nasdaq: XXII) to Participate in LD Micro, Roth Capital Investor Meetings

    BUFFALO, N.Y., May 27, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology, today announced that James A. Mish, Chief Executive Officer, and Richard Fitzgerald, Chief Financial Officer, will host meetings with investors at two upcoming investor conference events in June 2022. Event:LD Micro Invitational XII (in person)Date